Skip to main content
Published locations for CML-CP: Imatinib at higher dose or in combination with other drugs offers no survival benefit
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CML-CP: Imatinib at higher dose or in combination with other drugs offers no survival benefit
User login
Username
Password
Reset your password
/content/cml-cp-imatinib-higher-dose-or-combination-other-drugs-offers-no-survival-benefit
/hematology-oncology/article/237190/cml/cml-cp-imatinib-higher-dose-or-combination-other-drugs-offers